Amino acid modified ionic liquid, its preparation method and application
Amino acid-modified ionic liquids improve drug delivery in the gastrointestinal tract, addressing the safety and absorption deficiencies of existing ionic liquids in drug delivery, and achieving higher drug bioavailability and safety.
Patent Information
- Application Number
- CN202310602534.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-26
- Publication Date
- 2026-05-19
- Estimated Expiration
- 2043-05-26
AI Technical Summary
Existing ionic liquids have shortcomings in drug delivery, including insufficient safety and absorption-enhancing effectiveness. In particular, they have low oral bioavailability for macromolecular drugs and are unable to overcome multiple barriers in the gastrointestinal tract, such as mucus and intestinal epithelial barriers, which affects the solubility, permeability, and stability of the drugs.
A novel anion was prepared by modifying geraniol with amino acid-modified ionic liquids by introducing natural amino acids or amino acid repeating segments. The anion was then paired with alkyl quaternary ammonium ions containing hydroxyl groups to adjust the structure of the ionic liquid, thereby enhancing its permeability and biocompatibility in intestinal mucus and intestinal epithelium and reducing its toxicity to cells.
It significantly improved the oral bioavailability of the drug, enhanced the drug's penetration into intestinal mucus and intestinal epithelium, reduced the impact on the gut microbiota, and improved safety and delivery efficiency.
Smart Images

Figure BDA0004249524020000031 
Figure BDA0004249524020000032 
Figure BDA0004249524020000151